Association of peroxisome proliferator-activated receptorγ gene Pro12Ala and C161T polymorphisms with cardiovascular risk factors in maintenance hemodialysis patients

The Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor Gamma-2 Gene (PPARγ2) Is Associated with Increased Risk of Coronary Artery Disease: A Meta-Analysis

(2013) Zhijun Wu et al.   PLoS One

The effect of PPARG gene polymorphisms on the risk of coronary heart disease: a meta-analysis

(2012) Wenjun Xu et al.   MOLECULAR BIOLOGY REPORTS

The C161T polymorphism in the peroxisome proliferator-activated receptor gamma gene (PPARγ) is associated with risk of coronary artery disease: a meta-analysis

(2012) Zhijun Wu et al.   MOLECULAR BIOLOGY REPORTS

The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease

(2012) Saidan Ding et al.   WIENER KLINISCHE WOCHENSCHRIFT

Cardiovascular risk factors related to the PPARγ Pro12Ala polymorphism in patients with type 2 diabetes are gender dependent

(2011) Niclas Franck et al.   BLOOD PRESSURE

Role of Peroxisome Proliferator-Activated Receptor-γ in Atherosclerosis

(2011) Nanping Wang et al.   CIRCULATION JOURNAL

PPARα and PPARγ protect against HIV-1-induced MMP-9 overexpression via caveolae-associated ERK and Akt signaling

(2011) Wen Huang et al.   FASEB JOURNAL

Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes

(2011) Hulya Yilmaz-Aydogan et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

PPARγ Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes

(2009) Ulla Vogel et al.   BMC Medical Genetics

Effects of Thiazolidinediones Beyond Glycaemic Control

(2009) Rigas Kalaitzidis et al.   CURRENT PHARMACEUTICAL DESIGN

Searching for the right outcome? A systematic review and meta-analysis of controlled trials using carotid intima-media thickness or pulse wave velocity to infer antiatherogenic properties of thiazolidinediones

(2009) D. R. Webb et al.   DIABETES OBESITY & METABOLISM

Impact of the Pro12Ala Polymorphism of the PPAR-Gamma 2 Gene on Metabolic and Clinical Characteristics in the Palestinian Type 2 Diabetic Patients

(2009) S. Ereqat et al.   PPAR Research

Peroxisome Proliferator-Activated Receptor-Gamma Gene Polymorphism and Risk of Cardiovascular Disease in Patients with Diabetic Nephropathy

(2008) Cheuk-Chun Szeto et al.   AMERICAN JOURNAL OF NEPHROLOGY

Atherogenesis in Renal Patients: A Model of Vascular Disease?

(2008) Georgios Efstratiadis et al.   Current Vascular Pharmacology